Ajanta Pharmaceuticals Jammu Profile
Key Indicators
- Authorised Capital ₹ 2.00 M
- Paid Up Capital ₹ 1.80 M
- Company Age 33 Year, 14 Days
- Last Filing with ROC 31 Mar 2024
- Satisfied Charges ₹ 9.00 M
- Revenue Growth -81.11%
- Profit Growth -89.58%
- Ebitda -88.65%
- Net Worth 0.15%
- Total Assets -1.53%
About Ajanta Pharmaceuticals Jammu
Ajanta Pharmaceuticals Jammu Private Limited (APJPL) is a Private Limited Indian Non-Government Company incorporated in India on 17 January 1992 and has a history of 33 years. Its registered office is in Jammu And Kashmir, Jammu & Kashmir.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 2.00 M and a paid-up capital of Rs 1.80 M.
The company has closed loans amounting to ₹9.00 M, and has no open charges as per Ministry of Corporate Affairs (MCA) records.
Vijay Gupta, Anil Gupta, Kamal Gupta, and Two other members serve as directors at the Company.
Company Details
- LocationJammu And Kashmir, Jammu & Kashmir
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
-
- Social Media-
Corporate Identity Details
- CIN/LLPIN
U24231JK1992PTC001290
- Company No.
001290
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
17 Jan 1992
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Jammu
Industry
Who are the key members and board of directors at Ajanta Pharmaceuticals Jammu?
Board Members (5)
Name | Designation | Appointment Date | Status |
---|---|---|---|
Vijay Gupta | Director | 17-Jan-1992 | Current |
Anil Gupta | Director | 17-Jan-1992 | Current |
Kamal Gupta | Director | 17-Jan-1992 | Current |
Arun Gupta | Director | 17-Jan-1992 | Current |
Sushma Gupta | Director | 17-Jan-1992 | Current |
Financial Performance of Ajanta Pharmaceuticals Jammu.
Ajanta Pharmaceuticals Jammu Private Limited, for the financial year ended 2022, experienced significant reduction in revenue, with a 81.11% decrease. The company also saw a substantial fall in profitability, with a 89.58% decrease in profit. The company's net worth moved up by a moderate rise of 0.15%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
---|---|---|---|---|---|---|---|
Total Revenue |
| ||||||
Revenue from Operations |
| ||||||
Total Assets |
| ||||||
Profit or Loss |
| ||||||
Net Worth |
| ||||||
EBITDA |
|
What is the Ownership and Shareholding Structure of Ajanta Pharmaceuticals Jammu?
In 2022, Ajanta Pharmaceuticals Jammu had a promoter holding of 27.78% and a public holding of 72.22%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
₹0
₹9.00 M
Charges Breakdown by Lending Institutions
- The Jammu And Kashmir Bank Limited : 0.90 Cr
Latest Charge Details
Date | Lender | Amount | Status |
---|---|---|---|
04 Jan 2008 | The Jammu And Kashmir Bank Limited | ₹9.00 M | Satisfied |
How Many Employees Work at Ajanta Pharmaceuticals Jammu?
Unlock and access historical data on people associated with Ajanta Pharmaceuticals Jammu, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Ajanta Pharmaceuticals Jammu, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Ajanta Pharmaceuticals Jammu's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.